Valiant Organics

Why is Valiant Organics Ltd falling/rising?

As of 22-Jul, Valiant Organics Ltd's stock is experiencing a decline of -2.45 (-0.93%) and has lost -6.24% over the past three days, significantly underperforming the Sensex with a -33.60% return over the last year. Despite some positive financial results, long-term fundamentals are concerning, leading to weak overall performance and declining investor participation.

As of 22-Jul, Valiant Organics Ltd's stock price is currently falling, as indicated by a change of -2.45 (-0.93%). The stock has been on a downward trend, having lost value for the last three consecutive days, resulting in a total decline of -6.24% during this period. Additionally, the stock has underperformed significantly compared to the benchmark Sensex, with a -33.60% return over the past year, while the Sensex has only declined by -6.61%.<BR><BR>Despite a brief opening gain of 4.89% today, the stock's overall performance remains weak, trading below its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day). This suggests a lack of upward momentum. Furthermore, investor participation appears to be declining, as evidenced by a -63.86% drop in delivery volume compared to the 5-day average.<BR><BR>While there have been some positive financial results, such as a significant increase in profits and a very attractive valuation relative to peers, the long-term fundamentals are concerning. The company has experienced a -22.98% compound annual growth rate (CAGR) in operating profits over the last five years, and domestic mutual funds hold no stake in the company, which may indicate a lack of confidence in its future performance. Overall, these factors contribute to the stock's current decline.

Which are the latest news on Valiant Organics?

Should I buy, sell or hold Valiant Organics Ltd?

What does Valiant Organics do?

Valiant Organics Ltd is a specialty chemical manufacturer focused on Agro Intermediate and Pharma sectors, with a market cap of INR 779 Cr. As of March 2026, it reported net sales of 218 Cr and a net profit of 16 Cr.

Overview:<BR>Valiant Organics Ltd is a specialty chemical manufacturer operating in the Agro Intermediate and Pharma sectors within the Micro Cap market.<BR><BR>History:<BR>Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' in 2005. It transitioned to a Public Limited Company and changed its name on July 31, 2015. The most recent quarterly results reported net sales and profit for March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 218 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 16 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 779 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 25.00<BR>- Industry P/E: 34<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.33<BR>- Return on Equity: 3.91%<BR>- Price to Book: 1.06<BR><BR>Contact Details:<BR>Address: 109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080 <BR>Tel: 91-22-25913767/3766/67976640/5 <BR>Email: investor@valiantorganics.com <BR>Website: http://www.valiantorganics.com

How big is Valiant Organics?

As of 10th June, Valiant Organics Ltd has a market capitalization of 779.00 Cr, with net sales of 738.77 Cr and a net profit of 33.24 Cr reported in the latest four quarters.

As of 10th June, Valiant Organics Ltd has a market capitalization of 779.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Valiant Organics reported net sales of 738.77 Cr and a net profit of 33.24 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing shareholder's funds of 725.26 Cr and total assets of 1,182.93 Cr.

Who are in the management team of Valiant Organics?

The management team of Valiant Organics includes key members such as Navin Chapshi Shah (Chairman), Arvind Chheda (Managing Director), and several Executive and Non-Executive Directors, all contributing to the company's strategic direction.

The management team of Valiant Organics includes the following key members:<BR><BR>1. **Navin Chapshi Shah** - Chairman & Independent Director<BR>2. **Arvind Chheda** - Executive Director, Managing Director, Chief Financial Officer, and Promoter<BR>3. **Mahek Manoj Chheda** - Executive Director & Wholetime Director<BR>4. **Nemin Mahesh Savadia** - Executive Director<BR>5. **Sathiababu Krishnan Kallada** - Non-Executive & Non-Independent Director<BR>6. **Siddharth D. Shah** - Executive Director<BR>7. **Vishnu Sawant** - Executive Director & Wholetime Director<BR>8. **Kiritkumar Haribhai Desai** - Non-Executive & Non-Independent Director<BR>9. **Santosh S. Vora** - Non-Executive Director<BR>10. **Mulesh Manilal Savla** - Independent Non-Executive Director<BR>11. **Sonal A Vira** - Independent Director<BR>12. **Sudhirprakash Baburao Sawant** - Independent Director<BR><BR>This team plays a crucial role in the strategic direction and management of the company.

Who are the peers of the Valiant Organics?

Valiant Organics' peers include Sunshield Chem., Jyoti Resins, and Indo Amines, among others. In terms of performance, Sunshield Chem. leads with a 1-year return of 55.61%, while Valiant Organics has a return of -44.11%.

Peers: The peers of Valiant Organics are Sunshield Chem., Jyoti Resins, Indo Amines, Gem Aromatics, Sudarshan Pharma, Fairchem Organic, Chemcon Special., Jayant Agro Org., Amal, and Sacheerome.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jyoti Resins, while Average management risk is found at Sunshield Chem., Indo Amines, Gem Aromatics, Sudarshan Pharma, Valiant Organics, Fairchem Organic, Jayant Agro Org., and Amal, and the rest. Excellent growth is noted at Jyoti Resins and Amal, while Average growth is seen at Sunshield Chem., Sudarshan Pharma, Fairchem Organic, Jayant Agro Org., and Valiant Organics, and the rest. Below Average growth is present at Indo Amines, Gem Aromatics, and Chemcon Special., while the rest have Below Average growth. Good capital structure is found at Jyoti Resins, Chemcon Special., and Amal, while Average capital structure is noted at Sunshield Chem., Valiant Organics, and the rest, and Below Average capital structure is seen at Indo Amines, Sudarshan Pharma, and Fairchem Organic.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sunshield Chem. at 55.61%, while Jyoti Resins has the lowest at -34.34%. Valiant Organics' 1-year return of -44.11% is lower than both. Additionally, Chemcon Special., Fairchem Organic, Amal, and Valiant Organics have negative six-month returns.

Are Valiant Organics Ltd latest results good or bad?

Valiant Organics Ltd's latest quarterly results are strong, with a 330.68% increase in net profit and a 36.74% rise in revenue. However, the company has faced two consecutive annual losses and low return on equity, indicating ongoing financial challenges despite the recent positive performance.

Valiant Organics Ltd's latest results present a mixed picture. On the positive side, the company reported a significant turnaround in Q4 FY26, with a consolidated net profit of ₹15.72 crores, reflecting a remarkable 330.68% increase quarter-on-quarter. Revenue also saw a substantial rise of 36.74% to ₹217.78 crores, marking the highest quarterly revenue in the company's recent history. The operating margin improved to 12.16%, indicating a recovery from previous quarters.<BR><BR>However, despite this strong quarterly performance, the overall annual results raise concerns. For FY25, Valiant Organics reported a marginal net loss of ₹2 crores on revenues of ₹718 crores, representing a slight decline in sales compared to the previous year. This marked the second consecutive year of losses, following a ₹6 crore loss in FY24. The company's return on equity (ROE) is also notably low at 3.18%, indicating inefficiencies in generating returns for shareholders.<BR><BR>Additionally, the stock has underperformed compared to the specialty chemicals sector and the broader market, with a 12.53% decline over the past year. This underperformance, combined with concerns about margin volatility and the absence of institutional investor interest, suggests that while the latest quarterly results are strong, they do not fully address the underlying challenges facing the company.<BR><BR>In summary, while the recent quarterly results show promise, the broader context indicates ongoing financial difficulties and operational inefficiencies, making the overall assessment of Valiant Organics' performance more cautious.

When is the next results date for Valiant Organics Ltd?

The next results date for Valiant Organics Ltd is 16 May 2026.

The next results date for Valiant Organics Ltd is scheduled for 16 May 2026.

Is Valiant Organics technically bullish or bearish?

As of December 1, 2025, the trend is mildly bearish due to bearish momentum from the weekly MACD and Bollinger Bands, although monthly indicators suggest potential for recovery.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish momentum. The daily moving averages also reflect a bearish outlook. However, the monthly MACD and KST show mildly bullish signals, suggesting some potential for recovery over a longer time frame. Overall, the lack of strong bullish signals and the prevailing bearish indicators indicate a cautious approach is warranted.

Is Valiant Organics overvalued or undervalued?

As of November 27, 2025, Valiant Organics is considered overvalued with a PE ratio of 30.94 and an EV to EBITDA of 11.73, especially when compared to peers like Cipla and Sun Pharma, and has underperformed the Sensex with a year-to-date return of -14.77%.

As of 27 November 2025, Valiant Organics has moved from a very attractive to an attractive valuation grade. The company appears to be overvalued based on its current metrics. The PE ratio stands at 30.94, while the EV to EBITDA is 11.73 and the PEG ratio is notably low at 0.18, indicating potential overvaluation compared to growth expectations.<BR><BR>In comparison to its peers, Valiant Organics' valuation seems less favorable. For instance, Sun Pharma has a PE ratio of 37.62 and an EV to EBITDA of 24.87, categorizing it as expensive, while Cipla, also rated attractive, has a PE of 22.67 and an EV to EBITDA of 16.04. Furthermore, Valiant's recent stock performance has lagged significantly behind the Sensex, with a year-to-date return of -14.77% compared to the Sensex's 9.70%, reinforcing the notion that it may be overvalued in the current market context.

How has been the historical performance of Valiant Organics?

Valiant Organics has faced significant fluctuations in financial performance, with net sales declining from 1,051.80 Cr in March 2023 to 718.76 Cr in March 2025, while profitability metrics have also decreased, resulting in a negative profit after tax of -2.67 Cr in March 2025. Despite a slight recovery in operating profit, the overall financial environment remains challenging.

Answer:<BR>The historical performance of Valiant Organics has shown significant fluctuations over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Valiant Organics reported net sales of 718.76 Cr in March 2025, a slight decline from 723.06 Cr in March 2024 and a notable decrease from 1,051.80 Cr in March 2023. The total operating income mirrored this trend, falling to 718.76 Cr in March 2025 from 723.06 Cr in the previous year and down from 1,051.80 Cr in March 2023. The raw material costs also decreased to 440.07 Cr in March 2025 from 483.40 Cr in March 2024, contributing to a total expenditure of 665.09 Cr in March 2025, which was lower than 684.81 Cr in March 2024. Operating profit (PBDIT) rose to 62.31 Cr in March 2025 from 47.55 Cr in March 2024, but this was significantly lower than the 172.26 Cr reported in March 2023. The profit before tax showed a recovery to 2.91 Cr in March 2025 from a loss of 7.13 Cr in March 2024, yet it was down from 137.18 Cr in March 2023. The profit after tax remained negative at -2.67 Cr in March 2025, although it improved from -6.84 Cr in March 2024. The consolidated net profit also reflected this trend, standing at -3.74 Cr in March 2025 compared to -8.39 Cr in March 2024 and a profit of 88.12 Cr in March 2023. Total assets decreased to 1,182.93 Cr in March 2025 from 1,247.96 Cr in March 2024, while total liabilities also fell to 1,182.93 Cr from 1,247.96 Cr. Cash flow from operating activities was 56.00 Cr in March 2025, down from 84.00 Cr in March 2024, indicating a decline in cash generation capabilities. Overall, Valiant Organics has experienced a challenging financial environment with fluctuating sales and profitability metrics over the past few years.

Who are the top shareholders of the Valiant Organics?

The top shareholders of Valiant Organics include promoter Jaya Chandrakant Gogri with 8.25% and public shareholder Nikhil Parimal Desai with 9.17%. Individual investors hold 37.41%, while 17 foreign institutional investors hold a combined 0.37%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Valiant Organics include Jaya Chandrakant Gogri, who is the promoter with the highest holding at 8.25%. Additionally, the highest public shareholder is Nikhil Parimal Desai, holding 9.17%. Individual investors collectively hold a significant portion of the company at 37.41%. There are also 17 foreign institutional investors (FIIs) that hold a combined 0.37% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

What is the bonus history of the Valiant Organics?

Valiant Organics issued a 1:1 bonus share on December 24, 2020, with a record date of December 28, 2020, effectively doubling shareholders' holdings.

Valiant Organics has a bonus history that includes a notable 1:1 bonus issue announced with an ex-date of December 24, 2020. The record date for this bonus was December 28, 2020. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time. If you have any more questions about Valiant Organics or need further details, feel free to ask!

Has Valiant Organics declared dividend?

Valiant Organics Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of February 10, 2023. However, the company has shown significant variability in total returns, with negative returns in longer periods and a dividend yield of 0%.

Valiant Organics Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 10 Feb 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 27.24%, the dividend return was 0%, resulting in a total return of 27.24%.<BR><BR>Over the past year, the price return was 10.57%, with a dividend return of 0%, leading to a total return of 10.57%.<BR><BR>In the 2-year period, the price return was -29.27%, the dividend return was 0%, resulting in a total return of -29.27%.<BR><BR>For the 3-year period, the price return was -34.02%, with a dividend return of 0.86%, culminating in a total return of -33.16%.<BR><BR>In the 4-year period, the price return was -72.23%, the dividend return was 0.30%, resulting in a total return of -71.93%.<BR><BR>Over the last 5 years, the price return was -35.84%, with a dividend return of 1.14%, leading to a total return of -34.7%.<BR><BR>Overall, while Valiant Organics has declared a dividend, the total returns over various periods show significant variability, with some periods reflecting negative returns, particularly in the longer term. The absence of a consistent dividend yield further indicates challenges in maintaining shareholder value.